AXDX: Accelerate Diagnostics Inc. Kapitalizatsiyaning daromadga nisbati

Accelerate Diagnostics Inc. (AXDX) kompaniyasining korporativ logotipi

Accelerate Diagnostics (AXDX) kompaniyasining P/S ko'rsatkichi asosidagi biznes qiymati likvidlik yetishmovchiligi va kliniklarda mahsulotlarning sekin joriy etilishi tufayli kuchaygan tebranishlarni namoyish etmoqda. 0.10 savdo to'siqlari va komponentlar yetkazib berishdagi uzilishlarga bog'liq bo'lgan so'nggi baholash metrikasini belgilaydi. Biroq, bakteremiaga qarshi kurashish uchun PhenoTest tizimlarining joriy etilishi AXDX bozor qiymatining kelgusidagi o'sishi uchun asos yaratadi.

AXDX Accelerate Diagnostics, Inc: P/S multiplikatori 04.07.2022 - 24.05.2025 oraligʻida

Accelerate Diagnostics, Inc (AXDX) kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Aksiya narxi acceleratediagnostics.com|AXDX - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi haqida ma'lumot:
Bozor bahosi Accelerate Diagnostics, Inc|AXDX - Korxona qiymati
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya uchun buxgalteriya qiymati Accelerate Diagnostics|AXDX - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti acceleratediagnostics.com|AXDX - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Accelerate Diagnostics|AXDX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Accelerate Diagnostics Inc|AXDX - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Accelerate Diagnostics, Inc|AXDX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Accelerate Diagnostics|Oraliq likvidlik koeffitsiyenti acceleratediagnostics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
AXDX - Sof foyda|Kutilayotgan sof foyda Accelerate Diagnostics|AXDX - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Accelerate Diagnostics Inc.|AXDX - PEG multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Accelerate Diagnostics, Inc|AXDX - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Accelerate Diagnostics|AXDX - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi acceleratediagnostics.com|AXDX - Joriy yilda foyda o'sishi|Keyingi yil uchun bitta aksiya uchun sof foyda o'sishi prognozi Accelerate Diagnostics
- emitentning tushumi va sotuvlari tafsilotlari:
AXDX - Kompaniya daromadi|Kompaniya daromadi prognozi acceleratediagnostics.com|AXDX - Narxning daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Accelerate Diagnostics, Inc
Kompaniyaning fundamental tahlili:acceleratediagnostics.com, AXDX
Accelerate Diagnostics, Inc. tovar namunasi

P/S koeffitsiyenti Accelerate Diagnostics (AXDX) bozor qiymatini uning generatsiya qilgan daromadlari bilan solishtiradi va bozor sotuvlarning har bir dollari uchun qancha premium to'lashga tayyorligini aniqlaydi. P/S koeffitsiyenti tendentsiyasini tahlil qilish orqali investor sepsis diagnostikasi sarf materiallari sotuvidan takrorlanuvchi daromad modeliga o'tishning samaradorligini baholashi va aktivning bozor tomonidan qadrsizlanganini o'z vaqtida aniqlashi mumkin.

Raqobatdosh kompaniyalar

P/S multiplikatori agilent.com (A)|P/S multiplikatori DGX (Quest Diagnostics Incorporated)|ILMN - Kapitalizatsiyaning daromadga nisbati|Cologuard - P/S multiplikatori|Revvity Corp (RVTY) - Kapitalizatsiyaning daromadga nisbati|BIO: P/S multiplikatori|Sotuvga nisbatan narx anbio.com (NNNN)|Narxning daromadga nisbati Sotera Health|Narxning daromadga nisbati QDEL|P/S multiplikatori OPK|CDNA - Sotuvga nisbatan narx|Narxning daromadga nisbati Maravai LifeSciences MRVI|Bozor kapitallashuvining daromadga nisbati FLGT|Standard BioTools - P/S multiplikatori|CTKB - P/S multiplikatori|OSUR (OraSure Technologies Inc) - Kapitalizatsiyaning daromadga nisbati|XGN: Kapitalizatsiyaning sotish hajmiga nisbati|MDXH (MDxHealth SA) - P/S multiplikatori|Sotuvga nisbatan narx luciddx.com LUCD|Kapitalizatsiyaning daromadga nisbati PRE (Prenetics Global)|IMDX (imdxinc.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori TRIB (Trinity Biotech)|PRPH: Kapitalizatsiya va daromad nisbati|Ainos, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti codiagnostics.com CODX|HSCS: P/S multiplikatori|Biomerica Inc. (BMRA) - P/S multiplikatori|CDIO (Cardio Diagnostics Holdings Inc.) - P/S multiplikatori|ONCO - Narx/daromad multiplikatori|Narxning daromadga nisbati Virax Biolabs Group (VRAX)|bluejaydx.com - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati Aspira Women's Health Inc. AWH|Centogene N.V. (CNTG) - Sotuvga nisbatan narx|ENZ - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Fresh2 Group Limited FRES|GENE (gtglabs.com) - Kapitalizatsiyaning daromadga nisbati|ME: Kapitalizatsiyaning sotish hajmiga nisbati|PMD (Psychemedics Corporation) - P/S multiplikatori